[
ACS Meas Sci Au,
2022]
The fluorescence intensity emitted by nitrogen-vacancy (NV) centers in diamond nanoparticles can be readily modulated by the application of a magnetic field using a small electromagnet. By acquiring interleaved images acquired in the presence and absence of the magnetic field and performing digital subtraction, the fluorescence intensity of the NV nanodiamond can be isolated from scattering and autofluorescence even when these backgrounds are changing monotonically during the experiments. This approach has the potential to enable the robust identification of nanodiamonds in organisms and other complex environments. Yet, the practical application of magnetic modulation imaging to realistic systems requires the use of quantitative analysis methods based on signal-to-noise considerations. Here, we describe the use of magnetic modulation to analyze the uptake of diamond nanoparticles from an aqueous environment into Caenorhabditis elegans, used here as a model system for identification and quantification of nanodiamonds in complex matrices. Based on the observed signal-to-noise ratio of sets of digitally subtracted images, we show that nanodiamonds can be identified on an individual pixel basis with a >99.95% confidence. To determine whether surface functionalization of the nanodiamond significantly impacted uptake, we used this approach to analyze the presence of nanodiamonds in C. elegans that had been exposed to these functionalized nanodiamonds in the water column, with uptake likely occurring by ingestion. In each case, the images show a significant nanoparticle uptake. However, differences in uptake between the three ligands were not outside of the experimental error, indicating that additional factors beyond the surface charge are important factors controlling uptake. Analysis of the number of pixels above the threshold in individual C. elegans organisms revealed distributions that deviate significantly from a Poisson distribution, suggesting that uptake of nanoparticles may not be a statistically independent event. The results presented here demonstrate that magnetic modulation combined with quantitative analysis of the resulting images can be used to robustly characterize nanoparticle uptake into organisms.
Yang B, Hull MV, Hubner MP, Chu XJ, Ehrens A, Gandjui NV, Metuge HM, Murphy E, Chounna PW, Archer J, Hoerauf A, Kuhen KL, Xiong W, Tremblay MS, McNamara CW, Akumtoh DN, Wanji S, Chappell L, Pionnier N, Sjoberg H, Frohberger SJ, Steven A, Liu R, Gagaring K, Petrassi HM, Bakowski MA, Guo H, Olejniczak J, Landmann F, Woods AK, Turner JD, Joseph SB, Kwenti TDB, Schultz PG, Ndzeshang BL, Lenz F, Fombad FF, Struever D, Dubben B, Roland J, Njouendou AJ, Chatterjee AK, Chunda VC, Shiroodi RK, Sullivan W, White PM, Taylor MJ, Debec A
[
Sci Transl Med,
2019]
Parasitic filarial nematodes cause debilitating infections in people in resource-limited countries. A clinically validated approach to eliminating worms uses a 4- to 6-week course of doxycycline that targets <i>Wolbachia</i>, a bacterial endosymbiont required for worm viability and reproduction. However, the prolonged length of therapy and contraindication in children and pregnant women have slowed adoption of this treatment. Here, we describe discovery and optimization of quinazolines CBR417 and CBR490 that, with a single dose, achieve >99% elimination of <i>Wolbachia</i> in the in vivo <i>Litomosoides sigmodontis</i> filarial infection model. The efficacious quinazoline series was identified by pairing a primary cell-based high-content imaging screen with an orthogonal ex vivo validation assay to rapidly quantify <i>Wolbachia</i> elimination in <i>Brugia pahangi</i> filarial ovaries. We screened 300,368 small molecules in the primary assay and identified 288 potent and selective hits. Of 134 primary hits tested, only 23.9% were active in the worm-based validation assay, 8 of which contained a quinazoline heterocycle core. Medicinal chemistry optimization generated quinazolines with excellent pharmacokinetic profiles in mice. Potent antiwolbachial activity was confirmed in <i>L. sigmodontis</i>, <i>Brugia malayi</i>, and <i>Onchocerca ochengi</i> in vivo preclinical models of filarial disease and in vitro selectivity against <i>Loa loa</i> (a safety concern in endemic areas). The favorable efficacy and in vitro safety profiles of CBR490 and CBR417 further support these as clinical candidates for treatment of filarial infections.